Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate Kit
Product Images NDC 68462-376

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate (NDC 68462-376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eestructure.jpg (Image 01)

FDA Label Image

Nestructure.jpg (Image 02)

FDA Label Image

Fig1.jpg (Image 03)

Fig1.jpg (Image 03)
This text represents a table showing the concentration of Norethindrone in pg/mL over time in hours.*
FDA Label Image

Fig2.jpg (Image 04)

FDA Label Image

Pregnancychart.jpg (Image 05)

Pregnancychart.jpg (Image 05)
This appears to be a table outlining different methods of contraception and their effectiveness in terms of preventing pregnancy. The table is divided into categories of "Fewer Pregnancies", "More Pregnancies", and "No Birth Control", with a range of different methods listed under each category. The methods of contraception listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The effectiveness of each method is indicated by the number of pregnancies per 100 women in one year.*
FDA Label Image

Blister.jpg (Image 06)

FDA Label Image

Carton.jpg (Image 07)

Carton.jpg (Image 07)
This is a description of a pharmaceutical product called Norethindrone Acetate and Ethinyl Estradiol Tablets USP with Ferrous Fumarate Tablets USP. The product contains 24 white mint-flavored tablets and no tables. Each white tablet contains 1mg of Norethindrone Acetate, USP, and 20mcg of Ethiny Estradiol, USP. Each brown tablet contains 75mg of Ferrous Fumarate, USP. The usual dosage is one tablet daily for 25 days as directed by a physician. The patient labeling included in each pouch is intended for the patient and should be dispensed with the blister card. The product should be stored at 20° to 25°C, and excursions are permitted between 15° to 30°C. The package is not child-resistant, and the medication should be kept out of the reach of children. The product does not protect against HIV and other sexually transmitted diseases. The product is manufactured by Glenmark Pharmaceuticals.*
FDA Label Image

Blister.jpg (Image 08)

FDA Label Image

Logo.jpg (Image 09)

FDA Label Image

Laminate.jpg (Image 10)

Laminate.jpg (Image 10)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.